Wed, April 12, 2023
Tue, April 11, 2023
Mon, April 10, 2023
Fri, April 7, 2023
Thu, April 6, 2023

Mayank Mamtani Maintained (XFOR) at Strong Buy with Decreased Target to $3 on, Apr 10th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-3-on-apr-10th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Mayank Mamtani of B. Riley Securities, Maintained "X4 Pharmaceuticals, Inc." (XFOR) at Strong Buy with Decreased Target from $7 to $3 on, Apr 10th, 2023.

Mayank has made no other calls on XFOR in the last 4 months.



There are 4 other peers that have a rating on XFOR. Out of the 4 peers that are also analyzing XFOR, 0 agree with Mayank's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Mayank


  • Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $4 on, Friday, March 24th, 2023
  • Swayampakula Ramakanth of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $3 on, Wednesday, March 22nd, 2023
  • Kristen Kluska of "Cantor Fitzgerald" Maintained at Buy and Held Target at $3 on, Wednesday, March 22nd, 2023
  • Edward Tenthoff of "Piper Sandler" Initiated at Buy and Held Target at $3 on, Monday, December 12th, 2022

Publication Contributing Sources